Exane Derivatives Cooper Companies, Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Cooper Companies, Inc. stock. As of the latest transaction made, Exane Derivatives holds 9 shares of COO stock, worth $655. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9
Previous 63
85.71%
Holding current value
$655
Previous $26,000
92.31%
% of portfolio
0.0%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding COO
# of Institutions
44Shares Held
1.91MCall Options Held
0Put Options Held
0-
Intermede Investment Partners LTD1.48MShares$108 Million3.24% of portfolio
-
Pictet Asset Management Sa Geneva 73, V8143KShares$10.4 Million0.07% of portfolio
-
Eaton Vance Management Boston, MA86.1KShares$6.27 Million0.03% of portfolio
-
Brant Point Investment Management LLC New York, NY79.3KShares$5.78 Million1.45% of portfolio
-
Crystal Rock Capital Management60.3KShares$4.39 Million2.61% of portfolio
About COOPER COMPANIES, INC.
- Ticker COO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 49,346,000
- Market Cap $3.59B
- Description
- The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...